AstraZeneca
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AstraZeneca and other ETFs, options, and stocks.About AZN
AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology.
AZN Key Statistics
Stock Snapshot
With a market cap of 261B, AstraZeneca(AZN) trades at $168.37. The stock has a price-to-earnings ratio of 24.95 and currently yields dividends of 1.68%.
On 2026-09-22, AstraZeneca(AZN) stock moved within a range of $166.74 to $169.35. With shares now at $168.37, the stock is trading +1.0% above its intraday low and -0.6% below the session's peak.
Trading activity shows a volume of 2.11M, compared to an average daily volume of 3.39M.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $145.79.
Over the past 52 weeks, AstraZeneca(AZN) stock has traded between a high of $212.71 and a low of $145.79.
AZN News
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. AstraZeneca has launched a new Phase 3b study in China that tracks real world out...
(RTTNews) - AstraZeneca (AZN, AZN.L, ZEG.DE, AZN.ST) and Daiichi Sankyo's (4568.T) Enhertu has been recommended for approval in the European Union by CHMP as a...
AstraZeneca ( (GB:AZN) ) has provided an update. Alexion, AstraZeneca Rare Disease, has secured a positive opinion from the European Medicines Agency’s CHMP ba...
Analyst ratings
100%
of 10 ratingsMore AZN News
Key Points Bristol Myers Squibb's stock is up more than 17% so far this year. The company could be acquired by AstraZeneca. Bristol Myers Squibb has increase...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. The QUARTZ study from AstraZeneca looks at how adults in the U.S. with asthma do...
Alexion, AstraZeneca (AZN) Rare Disease’s Klygefa has been recommended for approval in the European Union, EU, as an add-on to standard therapy for the treatmen...
AstraZeneca (AZN) and Daiichi Sankyo’s (DSNKY) Enhertu has been recommended for approval in the European Union, EU, as a monotherapy for the adjuvant treatment...
An announcement from AstraZeneca ( (GB:AZN) ) is now available. AstraZeneca disclosed that its chief executive officer, Pascal Soriot, purchased 60,000 ordinar...
AstraZeneca plc (GB:AZN) announced an update on their ongoing clinical study. The study, officially titled “A Phase I, Randomized, Double-blind, Placebo-contro...
Agence France-Presse / Getty Image The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET a...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.